We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach. These new members, along with our existing institutions, greatly enhance our ability to develop and implement cutting-edge, individualized treatment plans.
National Synovial Sarcoma Tumor Board Gains Widespread Adoption
The National Synovial Sarcoma Tumor Board, funded by the Spence Family Synovial Sarcoma Foundation, has become an essential collaborative hub for leading medical institutions across the country. This initiative, launched in partnership with CHOP and Penn Medicine, brings together top specialists to discuss complex Synovial Sarcoma cases, ensuring that patients receive expert-reviewed treatment recommendations regardless […]


